LEADER 05154oam 2200769I 450 001 9910790326403321 005 20230124190518.0 010 $a1-136-59624-0 010 $a1-283-52094-X 010 $a9786613833396 010 $a0-203-33256-3 010 $a1-136-59625-9 024 7 $a10.4324/9780203332566 035 $a(CKB)2670000000230887 035 $a(EBL)987918 035 $a(OCoLC)804661690 035 $a(SSID)ssj0000696563 035 $a(PQKBManifestationID)12328966 035 $a(PQKBTitleCode)TC0000696563 035 $a(PQKBWorkID)10682451 035 $a(PQKB)11063344 035 $a(MiAaPQ)EBC987918 035 $a(Au-PeEL)EBL987918 035 $a(CaPaEBR)ebr10589152 035 $a(CaONFJC)MIL383339 035 $a(OCoLC)804038669 035 $a(OCoLC)758983071 035 $a(FINmELB)ELB139092 035 $a(EXLCZ)992670000000230887 100 $a20180706d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aRegenerating bodies $etissue and cell therapies in the twenty-first century /$fJulie Kent 210 1$aAbingdon, Oxon ;$aNew York, N.Y. :$cRoutledge,$d2012. 215 $a1 online resource (241 p.) 225 1 $aGenetics and society 225 0$aGenetics and society 300 $aDescription based upon print version of record. 311 $a1-138-02011-7 311 $a0-415-68881-7 320 $aIncludes bibliographical references (p. [191]-208) and index. 327 $aCover; Regenerating Bodies; Copyright; Contents; Preface; Acknowledgements; 1. Commodifying tissues and cells: The new tissue economies; Introduction; Emerging bioeconomies; Sourcing tissues for health technologies; Engineering tissues; Stem cells; The skin business; Engineering skin; Conclusion; 2. Regenerative medicine: a paradigm shift?; Introduction; Continuities with the past: culturing cells; Governing science with new institutions: the UK Stem Cell Bank; Boundary making; Distributed networks, commercialization and therapeutic use of stem cells 327 $aInnovation, transplantation medicine and stem cell scienceInnovation in neuroscience using fetal tissue; Conclusion; 3. Regulation and governance of tissue- and cell-based therapies in Europe: Ethical controversy and the politics of risk; Introduction; Ethical controversy and the principle of subsidiarity; Banking communities; Industry and the regulatory state: regulating the market in human-tissue products; Conclusion; 4. A 'strict but permissive approach': A case study of UK regulation of human-tissue and cell therapies; Introduction; Progressive science and UK science policy 327 $aThe HFEA model, 1990-2008A national scandal: from professional self-regulation to a new regulatory order; Using human tissues in research; Tissue banking: therapeutic use of human tissue and cells; Regulating hybridity and boundary objects; Conclusion; 5. 'Football fields of skin': a masculinist dream?; Introduction; Gender, science and technology; Defining clinical (social) need; Cartilage repair and regeneration; Women's labour: gendering the bioeconomy; The fetal-tissue economy; Conclusion; 6. Remaking the self; Introduction; Technologies of the body; Multiplications; Self and other 327 $aBeing human, donating tissue for research and therapiesPlastic bodies; Culturing cells and regulating the self; Beyond limits: materiality and subjectivity; Towards a feminist bioethics of the body; Conclusion; 7. Life, death and immortality; Introduction; Women and embryos: informed consent; Abortion, fetal death, corpses and organ donation: the right to choose; From transplantation medicine to regenerative medicine: innovation stories; Feminist (embodied) futures?; Conclusion; Appendix; Notes; Bibliography; Index 330 $aThis exciting book examines how human tissues and cells are being exchanged, commodified and commercialized by new health technologies. Through a discussion of emergent global 'tissue economies' the author explores the social dynamics of innovation in the fields of tissue engineering and stem cell science. The book explores how regenerative medicine configures and conceptualizes bodies and argues that the development of regenerative medicine is a feminist issue. In Regenerating Bodies, Kent critically examines the transformative potential of regenerative medicine and 410 0$aGenetics and society (Series) 606 $aRegenerative medicine$xMoral and ethical aspects 606 $aStem cells$xResearch$xMoral and ethical aspects 606 $aMedical technology$xForecasting 606 $aFeminism and science 615 0$aRegenerative medicine$xMoral and ethical aspects. 615 0$aStem cells$xResearch$xMoral and ethical aspects. 615 0$aMedical technology$xForecasting. 615 0$aFeminism and science. 676 $a174.2/8 700 $aKent$b Julie$f1957-,$01465060 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910790326403321 996 $aRegenerating bodies$93674902 997 $aUNINA